Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for High-Risk myeloma: early use of smart immune therapies

NCT ID NCT05849610

First seen May 12, 2026 · Last updated May 21, 2026 · Updated 1 time

Summary

This study tests two new drug combinations (teclistamab plus daratumumab and talquetamab plus daratumumab) as early treatment for people newly diagnosed with a high-risk form of multiple myeloma, a blood cancer. The goal is to see if these treatments can make the cancer disappear completely at a very sensitive level. About 30 participants will receive these therapies after initial standard treatment, and researchers will monitor how well they work and any side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK DE NOVO MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Clinica Universidad de Navarra

    Pamplona, Spain

  • Complejo Hospitalario Santiago (CHUS)

    Santiago de Compostela, Spain

  • H. Universitario Marqués de Valdecilla

    Santander, Spain

  • Hospital Clinic i Provincial de Barcelona

    Barcelona, Spain

  • Hospital Doce de Octubre

    Madrid, 28041, Spain

  • Hospital Germans Trials i Pujol

    Badalona, Spain

  • Hospital Universitari i Politecnic la Fe

    Valencia, Spain

  • Hospital Universitario de Salamanca

    Salamanca, Spain

  • Hospital Virgen de la Arrixaca

    Murcia, Spain

  • Hospital Vírgen del Rocío

    Seville, Spain

Conditions

Explore the condition pages connected to this study.